Connecting the Dots: Diabetes, CKD, and CVD Pathways-Evidence-Based Screening & Early Intervention

Video Transcription

Video Summary

The lecture emphasizes the significance of evidence-based screening and early intervention to manage the interrelated conditions of diabetes, chronic kidney disease (CKD), and cardiovascular disease (CVD). These chronic conditions significantly heighten the risk of cardiovascular events and mortality. The Framingham study noted a considerable risk increase for CVD among diabetic patients, while the Emerging Risk Factors Collaboration linked diabetes to heightened mortality risk from cardiovascular events. CKD exacerbates this risk irrespective of severity, with studies like ACCORD and ADVANCE finding a substantial increase in CVD risk associated with mild CKD in diabetes. Managing these patients involves regular screening, lifestyle modifications, and pharmacological strategies to control glycemic levels, dyslipidemia, and hypertension. Screening tools like urine albumin-to-creatinine ratios and estimated GFR measurements help identify at-risk patients. Collaboration among medical professionals is crucial in providing appropriate risk assessments and tailoring preventive therapies, including decisions on aspirin use, considering the bleeding risks in CKD patients.

Keywords

diabetes

chronic kidney disease

cardiovascular disease

evidence-based screening

early intervention